Bahrain and Kuwait signed a memorandum of understanding (MoU) to enhance health co-operation between the two countries.
Health Minister Dr Jalila Al Sayyed and her Kuwaiti counterpart Dr Ahmad Al Awadhi signed the agreement on the sidelines of the 11th meeting of the CGG Health Ministers and the 88th (50th session) meeting of the GCC Health Ministers’ Council.
The MoU aims to strengthen collaboration in preventive and curative health services, twin healthcare institutions, and unify stances on regional and international health issues.
It also covers co-operation in public health programmes, combating communicable and non-communicable diseases, and sharing expertise in environmental health, climate change, and the One Health approach.
The MoU further includes co-operation in training, capacity building and professional development of health workers, as well as the use of digital health and modern technologies.
It promotes collaboration with the Kuwait Institute for Medical Specialisations, expanding training opportunities for Bahraini health professionals, and co-operation in telemedicine, health insurance systems, and comprehensive healthcare. It also supports school health development and pharmaceutical co-operation to ensure drug security.
The signing of the MoU reflects the shared keenness of both sides to consolidate their strategic partnership in the health field, contribute to sustainable health development, and enhance Gulf co-operation in addressing current and future health challenges.
The ministers underscored deep relations between Bahrain and Kuwait, and the growing co-operation across various domains, particularly in the health sector, in a way that serves shared interests and supports Gulf health integration.
They also discussed means to further develop bilateral health co-operation through the exchange of expertise and best practices in areas such as primary healthcare, disease prevention, and strengthening public health systems. Discussions also covered co-operation opportunities in health training, capacity development, and expanding partnerships in pharmaceuticals and medical technologies.
&uuid=(email))